MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG SPRUNG RESERVOIR; HYDROCEPHALUS MANAGEMENT

Model Number	FV043T
Medical Device Problem Code	Infusion or Flow Problem (2964)
Health Effect - Clinical Code	Insufficient Information (4580)
Date of Event	05/12/2023
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
Investigation on-going.Should relevant additional information / investigation results become available, a supplemental medwatch report will be submitted.
Event or Problem Description
It was reported to aesculap inc.That a sprung reservoir (product # fv043t) was implanted during a procedure performed on an unknown date.According to the complainant, the shunt system (sprung reservoir + m.Blue) showed a drainage problem.The patient underwent a revision procedure.The complaint devices were returned to the manufacturer for evaluation.No patient complications were reported as a result of the revision procedure.The adverse event is filed under aic reference (b)(4).Reference associated medwatch report # 2916714-2023-00068.
Additional Manufacturer Narrative
Manufacturing site evaluation: information about the complaint: information about the complaint are "shunt not draining properly." manufacturing and quality control data: due to the limited information investigation is restricted to tracability of manufacturing and quality control data.The sprung reservoir was manufactured by a qualified employee.Deviations during assembly did not occur.The product was finally tested as article fv043t and we confirm all parameters have been inspected and approved during the manufacturing.We assure that production and quality control ensure that only products that are conform to specifications are made available on the market.Conclusion information: an investigation was not possible because no release/questionnaire was sent to us.On the basis of the product documentation, we can exclude the presence of a defect at the time of delivery of the sprung reservoir since this documentation indicates that the valve is in perfect condition.Deposits caused by natural substances in the cerebrospinal fluid, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.Small amounts of non-visible deposits/proteins might compromise the integrity of the valve.Further actions: from our point of view, no further regulatory actions are required.
Event or Problem Description
Investigation complete.

• Brand Name: SPRUNG RESERVOIR
• Common Device Name: HYDROCEPHALUS MANAGEMENT
• Manufacturer (Section D): CHRISTOPH MIETHKE GMBH & CO KG; ulanenweg 2; potsdam, 14469 ; GM 14469
• MDR Report Key: 17073531
• Report Number: 2916714-2023-00067
• Device Sequence Number: 20365981
• Product Code: JXG
• UDI-Device Identifier: 04041906131364
• UDI-Public: 4041906131364
• Combination Product (Y/N): N
• Initial Reporter State: MI
• Initial Reporter Country: US
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Serviced by Third Party (Y/N): Unknown
• Reporter Type: Importer
• Initial Reporter Occupation: Physician
• Type of Report: Initial,Followup
• Report Date (Section B): 08/02/2023
• Report Date (Section F): 06/06/2023

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Model Number: FV043T
• Device Catalogue Number: FV043T
• Was Device Available for Evaluation?: No
• Date Returned to Manufacturer: 05/24/2023
• Is the Reporter a Health Professional?: Yes
• Was the Report Sent to FDA?: Yes
• Distributor Facility Aware Date: 05/12/2023
• Event Location: Hospital
• Date Report to Manufacturer: 05/12/2023
• Initial Date Received by Manufacturer: Not provided
• Supplement Date Received by Manufacturer: Not provided
• Initial Report FDA Received Date: 06/06/2023
• Supplement Report FDA Received Date: 08/02/2023
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Sex: Unknown
• Date Report Sent to FDA: 06/06/2023